Anyhow, substantial differences in the serum levels of these two cathepsins were observed between the rheumatoid arthritis patients with and without autoantibodies, suggesting specific roles of cathepsins S and L in disease development and progression in seropositive patients [150]. This evidence concerns the gene CTSS and rheumatoid arthritis.